Skip to content

Efficacy of conchotome muscle biopsy

Efficacy of conchotome muscle biopsy - Efficacy of conchotome muscle biopsy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020612
Enrollment
75
Registered
2016-02-01
Start date
2016-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cases who need muscle biopsy

Interventions

to employ conchotome muscle biopsy, once

Sponsors

Department of Rheumatology, Tokyo Medical and Dental University (TMDU)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.patients who need muscle biopsy for the diagnosis of polymyositis/dermatomyositis 2.patients who need muscle biopsy for the diagnosis of myopathy other than polymyositis/dermatomyositis 3.patients with polymyositis/dermatomyositis who need muscle biopsy for evaluating disease activity

Exclusion criteria

Exclusion criteria: patients whom investigators judge ineligible

Design outcomes

Primary

MeasureTime frame
efficiency of conchotome muslce biopsy for diagnosis of myopathy

Countries

Japan

Contacts

Public ContactNatsuka Umezawa

Tokyo Medical and Dental University (TMDU) Department of Rheumatology

umezawa.rheu@tmd.ac.jp03-3813-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026